Ophthalmology

The CGTLive™ Ophthalmology specialty topic page includes the most recent clinical care news related to the development of cell therapies, gene therapies, and engineered and regenerative medicines for disorders and diseases of the eye. It also contains video interviews with key opinion leaders in the field of ophthalmology discussing related FDA actions, clinical guideline updates, and clinical trial findings in the field of gene and cell therapy for ophthalmic conditions.

Latest News

SpliceBio Doses First Patient in Trial for Stargardt Gene Therapy SB-007
SpliceBio Doses First Patient in Trial for Stargardt Gene Therapy SB-007

March 16th 2025

The ASTRA and accompanying POLARIS studies are actively enrolling patients.

Around the Helix: Cell and Gene Therapy Company Updates – March 12, 2025
Around the Helix: Cell and Gene Therapy Company Updates – March 12, 2025

March 12th 2025

Stem Cell Therapy CALEC Restores Corneal Damage in Trial Led by Massachusetts Eye and Ear Investigators
Stem Cell Therapy CALEC Restores Corneal Damage in Trial Led by Massachusetts Eye and Ear Investigators

March 7th 2025

Data Roundup: February 2025 Features Updates from WORLDSymposium, Tandem Meetings, and More
Data Roundup: February 2025 Features Updates from WORLDSymposium, Tandem Meetings, and More

March 6th 2025

Neurotech’s Encapsulated Cell Therapy Encelto Approved by FDA for Macular Telangiectasia Type 2
Neurotech’s Encapsulated Cell Therapy Encelto Approved by FDA for Macular Telangiectasia Type 2

March 6th 2025

Video Interviews
Podcasts
ImmunoLogic
ImmunoLogic
ImmunoLogic

More News

© 2025 MJH Life Sciences

All rights reserved.